X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (206) 206
Publication (15) 15
Book / eBook (14) 14
Book Review (10) 10
Patent (8) 8
Magazine Article (5) 5
Newspaper Article (5) 5
Book Chapter (4) 4
Conference Proceeding (4) 4
Trade Publication Article (4) 4
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (93) 93
index medicus (93) 93
hematology (70) 70
male (63) 63
middle aged (63) 63
female (61) 61
aged (53) 53
adult (44) 44
life sciences (31) 31
oncology (28) 28
treatment outcome (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
cancer (22) 22
abridged index medicus (20) 20
aged, 80 and over (20) 20
cyclophosphamide (20) 20
leukemia, lymphocytic, chronic, b-cell - drug therapy (18) 18
chemotherapy (17) 17
prognosis (17) 17
rituximab (17) 17
retrospective studies (15) 15
therapy (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
disease-free survival (13) 13
lymphomas (13) 13
care and treatment (12) 12
lymphoma (12) 12
non-hodgkins-lymphoma (12) 12
survival rate (12) 12
antineoplastic agents - therapeutic use (11) 11
chronic lymphocytic leukemia (11) 11
research (11) 11
survival analysis (11) 11
cll (10) 10
cyclophosphamide - administration & dosage (10) 10
france (10) 10
human health and pathology (10) 10
leukemia (10) 10
recurrence (10) 10
survival (10) 10
diagnosis (9) 9
fludarabine (9) 9
follow-up studies (9) 9
time factors (9) 9
vidarabine - analogs & derivatives (9) 9
adolescent (8) 8
analysis (8) 8
antibodies, monoclonal, murine-derived - administration & dosage (8) 8
b-cell lymphoma (8) 8
cytarabine - administration & dosage (8) 8
history (8) 8
motion pictures (8) 8
prospective studies (8) 8
remission induction (8) 8
risk factors (8) 8
transplantation (8) 8
young adult (8) 8
antibodies, monoclonal, murine-derived - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
chronic lymphocytic-leukemia (7) 7
cyclophosphamide - therapeutic use (7) 7
film noir (7) 7
fixed constructions (7) 7
hematology, oncology and palliative medicine (7) 7
history and criticism (7) 7
leukemia, lymphocytic, chronic, b-cell - pathology (7) 7
measuring (7) 7
minimal residual disease (7) 7
physics (7) 7
testing (7) 7
antineoplastic agents - administration & dosage (6) 6
apoptosis (6) 6
building (6) 6
clinical trials (6) 6
immunology (6) 6
kaplan-meier estimate (6) 6
leukemia, lymphocytic, chronic, b-cell - genetics (6) 6
leukemia, lymphocytic, chronic, b-cell - mortality (6) 6
neoplasm staging (6) 6
oncology, experimental (6) 6
patients (6) 6
salvage therapy (6) 6
stem cells (6) 6
trial (6) 6
vidarabine - administration & dosage (6) 6
acute myeloid leukemia (5) 5
antineoplastic agents - adverse effects (5) 5
building implements or other building aids, or theiruse (5) 5
cyclophosphamide - adverse effects (5) 5
disease progression (5) 5
drug therapy (5) 5
fatal outcome (5) 5
forms (5) 5
france - epidemiology (5) 5
gastroenterology & hepatology (5) 5
gene (5) 5
gyroscopic instruments (5) 5
handling building materials on the site (5) 5
health aspects (5) 5
lymphoma, b-cell - pathology (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
UofT at Scarborough - Stacks (4) 4
Innis College - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Gerstein Science - Stacks (1) 1
Innis College - Reference (1) 1
Music - Stacks (1) 1
Robarts - Searching (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2010, Volume 363, Issue 26, pp. 2511 - 2521
In this study, adding pegylated interferon alfa-2a to imatinib therapy for chronic myeloid leukemia resulted in a greater reduction in the number of cells... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, GENERAL & INTERNAL | CHRONIC GRANULOCYTIC-LEUKEMIA | INTERFERON | POSITIVE CELLS | CHRONIC-PHASE | ABL TYROSINE KINASE | HEMATOPOIETIC STEM-CELLS | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | CYTARABINE | Piperazines - administration & dosage | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Proto-Oncogene Proteins c-abl - analysis | Cytarabine - adverse effects | Recombinant Proteins | RNA, Neoplasm - analysis | Adult | Female | Transcription, Genetic | Neutropenia - chemically induced | Proto-Oncogene Proteins c-abl - genetics | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Anemia - chemically induced | Treatment Outcome | Thrombocytopenia - chemically induced | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Leukemia, Myeloid, Chronic-Phase - mortality | Fusion Proteins, bcr-abl - genetics | Fusion Proteins, bcr-abl - analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Stem Cells - drug effects | Interferon-alpha - adverse effects | Benzamides | Drug therapy | Chronic myeloid leukemia | Medical research | Kinases | Leukemia | Manuscripts | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 1, pp. 48 - 53
Treatment of mantle cell lymphoma (MCL) in younger patients remains a challenge. We report results of a phase 2 trial using cytarabine and rituximab as... 
WORKSHOP | EUROPEAN-MCL-NETWORK | IMMUNOCHEMOTHERAPY | THERAPY | RESCUE | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | PROGRESSION-FREE SURVIVAL | HEMATOLOGY | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Mantle-Cell - surgery | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cisplatin - administration & dosage | Kidney Diseases - chemically induced | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Cytarabine - administration & dosage | Neoplasms, Second Primary - epidemiology | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Transplantation Conditioning | Peripheral Blood Stem Cell Transplantation | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2018, Volume 183, Issue 5, pp. 701 - 701
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 12/2018, Volume 183, Issue 5, pp. 701 - 701
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 06/2017, Volume 56, Issue 6, pp. 635 - 647
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2015, Volume 90, Issue 3, pp. 204 - 207
Journal Article